1. Home
  2. GBIO vs TISI Comparison

GBIO vs TISI Comparison

Compare GBIO & TISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • TISI
  • Stock Information
  • Founded
  • GBIO 2016
  • TISI 1973
  • Country
  • GBIO United States
  • TISI United States
  • Employees
  • GBIO N/A
  • TISI N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • TISI Other Consumer Services
  • Sector
  • GBIO Health Care
  • TISI Consumer Discretionary
  • Exchange
  • GBIO Nasdaq
  • TISI Nasdaq
  • Market Cap
  • GBIO 64.8M
  • TISI 68.1M
  • IPO Year
  • GBIO 2020
  • TISI N/A
  • Fundamental
  • Price
  • GBIO $0.78
  • TISI $17.36
  • Analyst Decision
  • GBIO Strong Buy
  • TISI
  • Analyst Count
  • GBIO 2
  • TISI 0
  • Target Price
  • GBIO $6.50
  • TISI N/A
  • AVG Volume (30 Days)
  • GBIO 649.2K
  • TISI 11.9K
  • Earning Date
  • GBIO 03-05-2025
  • TISI 03-06-2025
  • Dividend Yield
  • GBIO N/A
  • TISI N/A
  • EPS Growth
  • GBIO N/A
  • TISI N/A
  • EPS
  • GBIO N/A
  • TISI N/A
  • Revenue
  • GBIO $18,582,000.00
  • TISI $853,107,000.00
  • Revenue This Year
  • GBIO $212.74
  • TISI N/A
  • Revenue Next Year
  • GBIO N/A
  • TISI N/A
  • P/E Ratio
  • GBIO N/A
  • TISI N/A
  • Revenue Growth
  • GBIO 514.08
  • TISI N/A
  • 52 Week Low
  • GBIO $0.72
  • TISI $5.05
  • 52 Week High
  • GBIO $4.65
  • TISI $26.77
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 29.26
  • TISI 57.26
  • Support Level
  • GBIO $0.72
  • TISI $16.00
  • Resistance Level
  • GBIO $1.00
  • TISI $17.67
  • Average True Range (ATR)
  • GBIO 0.07
  • TISI 1.25
  • MACD
  • GBIO -0.00
  • TISI 0.08
  • Stochastic Oscillator
  • GBIO 18.68
  • TISI 64.87

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About TISI Team Inc.

Team Inc is a provider of specialty industrial services, including inspection, engineering assessment and mechanical repair and remediation required in maintaining high temperature and high-pressure piping systems and vessels that are utilized in refining, petrochemicals, and others. The company operates in two segments namely Inspection and Heat Treating Group and Mechanical Services Group. Inspection and Heat Treating Group provides non-destructive testing services for the process, pipeline and power sectors and others. The Mechanical Services Group provides call-out and turnaround services under both on-stream and shut down circumstances.

Share on Social Networks: